PATENT CLAIM ANALYSIS

Application Number: 15753008
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "406000"]

Abstract:
Disclosed herein is a compound of formula (I) and/or a pharmaceutically acceptable salt thereof that can serve as Erk inhibitors. They are potentially useful in the treatment of diseases treatable by inhibition of Erk, such as cancers. Also disclosed herein is a pharmaceutical composition, comprising a compound of formula I and/or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier.

Claim (Index 23):
A method of treating cancer in a patient, comprising administering to the patient in recognized need of such treatment, an effective amount of a pharmaceutical composition comprising a compound of  claim 1 , and/or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 88.0
- Lexical Diversity: 1.5814
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15352184', '14776280', '14135793', '14710631', '13855246']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8090566084223532
- 35 USC 102 Novelty (BERT): 0.5423004264826369
- Combined Prediction Score: 0.7823809902283816
- Mean Citation Score: 402.434838
- Max Citation Score: 408.44528
- Similarity Product: 285.0626023410988

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test